Literature DB >> 15028431

Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function.

Steven A Kaplan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028431     DOI: 10.1016/j.urology.2003.09.063

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  6 in total

1.  Medical therapy for benign prostatic hyperplasia: new terminology, new concepts, better choices.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2006

Review 2.  Primary care physician versus urologist: how does their medical management of LUTS associated with BPH differ?

Authors:  Martin M Miner
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

Review 3.  Ejaculatory disorders and lower urinary tract symptoms.

Authors:  Robert E Brannigan
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

Review 4.  Lower urinary tract symptoms and erectile dysfunction: epidemiology and treatment in the aging man.

Authors:  Shane Russell; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

5.  "Ejaculatory disorders and alpha1-adrenoceptor antagonists therapy: clinical and experimental researches".

Authors:  Marco Grasso; Flavio Fortuna; Caterina Lania; Salvatore Blanco
Journal:  J Transl Med       Date:  2006-07-14       Impact factor: 5.531

6.  Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia: a randomized controlled trial.

Authors:  Satabdi Pande; Avijit Hazra; Anup Kumar Kundu
Journal:  Indian J Pharmacol       Date:  2014 Nov-Dec       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.